<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Infection and Immunity</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Infection and Immunity</journal-title><trans-title-group xml:lang="ru"><trans-title>Инфекция и иммунитет</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2220-7619</issn><issn publication-format="electronic">2313-7398</issn><publisher><publisher-name xml:lang="en">SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">591</article-id><article-id pub-id-type="doi">10.15789/2220-7619-2017-4-341-349</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">FEATURES OF THE MICROBIOME OF THE UPPER RESPIRATORY TRACT IN CHILDREN WITH RECURRENT RESPIRATORY DISEASES</article-title><trans-title-group xml:lang="ru"><trans-title>ОСОБЕННОСТИ МИКРОБИОМА ВЕРХНИХ ОТДЕЛОВ РЕСПИРАТОРНОГО ТРАКТА У ДЕТЕЙ С РЕЦИДИВИРУЮЩИМИ РЕСПИРАТОРНЫМИ ЗАБОЛЕВАНИЯМИ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shabaldin</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Шабалдин</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, MD (Medicine), Leading Researcher, Laboratory of Cell Technologies, Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russian Federation; Professor of Department of Otolaryngology and Clinical Immunology, Kemerovo State Medical Academy</p></bio><bio xml:lang="ru"><p>д.м.н., ведущий научный сотрудник лаборатории клеточных технологий ФГБНУ НИИ комплексных проблем сердечно-сосудистых заболеваний, г. Кемерово, Россия; профессор кафедры оториноларингологии и клинической иммунологии ГБОУ ВПО Кемеровский государственный медицинский университет МЗ РФ</p></bio><email>weit2007@ya.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shabaldina</surname><given-names>E. V.</given-names></name><name xml:lang="ru"><surname>Шабалдина</surname><given-names>Е. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, MD (Medicine), Associate Professor, Head of the Department of Otorhinolaryngology and Clinical Immunology, Kemerovo State Medical Academy</p></bio><bio xml:lang="ru"><p>д.м.н., доцент, зав. кафедрой оториноларингологии и клинической иммунологии Кемеровской государственной медицинской академии</p></bio><email>weit2007@ya.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Simbirtsev</surname><given-names>A. S.</given-names></name><name xml:lang="ru"><surname>Симбирцев</surname><given-names>А. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>RAS Corresponding Member, PhD, MD (Biology), Professor, Deputy Director on Science of State Research Institute of Highly Pure Biopreparations</p></bio><bio xml:lang="ru"><p>член-корреспондент РАН, д.б.н., профессор, зам. директора по научной работе ФГУП ГосНИИ ОЧБ ФМБА</p></bio><email>weit2007@ya.ru</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Kemerovo State Medical Academy of Ministry of Health of Russia, Kemerovo</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО Кемеровский государственный медицинский университет Минздрава России, г. Кемерово</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo</institution></aff><aff><institution xml:lang="ru">ФГБНУ Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний, г. Кемерово</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">State Research Institute of Highly Pure Biopreparations FMBA of Russia, St. Petersburg</institution></aff><aff><institution xml:lang="ru">ФГБУП НИИ особо чистых биопрепаратов ФМБА России, Санкт-Петербург</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2017-12-17" publication-format="electronic"><day>17</day><month>12</month><year>2017</year></pub-date><volume>7</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>341</fpage><lpage>349</lpage><history><date date-type="received" iso-8601-date="2018-01-20"><day>20</day><month>01</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-01-20"><day>20</day><month>01</month><year>2018</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2017, Shabaldin A.V., Shabaldina E.V., Simbirtsev A.S.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2017, Шабалдин А.В., Шабалдина Е.В., Симбирцев А.С.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="en">Shabaldin A.V., Shabaldina E.V., Simbirtsev A.S.</copyright-holder><copyright-holder xml:lang="ru">Шабалдин А.В., Шабалдина Е.В., Симбирцев А.С.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://iimmun.ru/iimm/article/view/591">https://iimmun.ru/iimm/article/view/591</self-uri><abstract xml:lang="en"><p>Studies of the metagenome of the upper respiratory tract in children showed the presence of five major bacterial phyla: Proteobacteria, Firmicutes, Bacteroidetes, Actinobacteria and Fusobacteria. Were revealed population differences in the distribution of weights of the above listed phyla, but subject to the dominance of the Firmicutes. Proved the role of environmental factors and time of year for representation in these biotopes of the phyla: Firmicutes, Proteobacteria, Bacteroidetes. Recurrent respiratory infections, hypertrophy of the tonsils of the lymphoid pharyngeal ring, secretory middle ear infections in children is associated with carriage of Haemophilus (H.) parainfluenzae, H. paraphrohaemolyticus, Gemella (G.) haemolysans, G. morbillorum, G. sanguinis, Streptococcus (S.) pneumoniae, S. pseudopneumoniae, S. intermedius, S. agalactiae.</p><p> </p></abstract><trans-abstract xml:lang="ru"><p>Исследования метагенома верхних отделов респираторного тракта у детей показали присутствие пяти основных бактериальных филумов: Proteobacteria, Firmicutes, Bacteroidetes, Actinobacteria и Fusobacteria. Выявлены популяционные различия в распределении удельных весов выше перечисленных филумов, но с обязательным доминированием Firmicutes. Доказана роль факторов окружающей среды и времени года на представительство в этих биотопах филумов Firmicutes, Proteobacteria, Bacteroidetes. Рецидивирующие респираторные инфекции, гипертрофия миндалин лимфоидного глоточного кольца, секреторные средние отиты у детей ассоциированы с носительством Haemophilus (H.) parainfluenzae, H. paraphrohaemolyticus, Gemella (G.) haemolysans, G. morbillorum, G. sanguinis, Streptococcus (S.) pneumoniae, S. pseudopneumoniae, S. intermedius, S. agalactiae.</p><p> </p></trans-abstract><kwd-group xml:lang="en"><kwd>dysbiosis of the upper respiratory tract</kwd><kwd>bacterial phyla</kwd><kwd>hypertrophy of the tonsils of the lymphoid pharyngeal ring</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>дисбиоз верхних дыхательных путей</kwd><kwd>бактериальные филумы</kwd><kwd>гипертрофия миндалин лимфоидного глоточного кольца</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1.Альбицкий В.Ю., Баранов А.А. Часто болеющие дети. Клинико-социальные аспекты. Пути оздоровления. Саратов: Саратовский национальный исследовательский государственный университет им. Н.Г. Чернышевского, 1986. 184 с. [Albitsky V.Yu., Baranov A.A. Chasto boleyushchie deti. Kliniko-sotsial’nye aspekty. Puti ozdorovleniya [Frequently ill children. Clinical and social aspects. The road to recovery]. Saratov: N.G. Chernyshevsky Saratov National Research University, 1986. 184 p.]</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2.Бонч-Осмоловская Е.А., Равин Н.В. Анализ полных геномов — очередной этап в развитии микробиологии // Вестник Российской академии наук. 2010. Т. 80, № 11. С. 977–984. [Bonch-Osmolovskaya E.A., Ravin N.V. Analysis of complete genome as successive stage in development of microbiology review. Vestnik Rossiiskoi akademii nauk = Herald of the Russian Academy of Sciences, 2010, vol. 80, no. 11, pp. 977–984. (In. Russ.)]</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3.Волкова Р.А., Сколетнева Е.С., Эльберт Е.В., Мыца Е.Д., Давыдов Д.С., Мовсесянц А.А., Меркулов В.А., Бондарев В.П., Борисевич И.В. Проблемы генотипирования микроорганизмов // БИОпрепараты. Профилактика, диагностика, лечение. 2016. Т. 16, № 3 (59). С. 139–144. [Volkova R.A., Skoletneva E.S., El’bert E.V., Mytsa E.D., Davydov D.S., Movsesyants A.A., Merkulov V.A., Bondarev V.P., Borisevich I.V. Genotyping problems of microorganisms. BIOpreparaty. Profilaktika, diagnostika, lechenie = BIO Preparations. Prevention, Diagnosis, Treatment, 2016, vol. 16, no. 3 (59), pp. 139–144. (In Russ.)]</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4.Карпова Е.П., Тулупов Д.А. Хронический аденоидит у детей: пособие для врачей. М.: РМАПО, 2009. 54 с. [Karpova E.P., Tulupov D.A. Khronicheskii adenoidit u detei: posobie dlya vrachei [Chronic adenoiditis in children: manual for physicians]. Moscow: Russian Medical Academy, 2009. 54 p.]</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5.Кушнарева М.В., Виноградова Т.В., Кешишян Е.С., Парфенов В.В., Кольцов В.Д., Брагина Г.С., Паршина О.В., Гусева Т.С. Особенности иммунного статуса и системы интерферона у детей раннего возраста // Российский вестник перинатологии и педиатрии, 2016. Т. 61, № 3. С. 12–21. [Kushnareva M.V., Vinogradova T.V., Keshishian E.S., Parfenov V.V., Koltsov V.D., Bragina G.S., Parshina O.V., Guseva T.S. Specific features of the immune status and interferon system of infants. Rossiyskiy vestnik perinatologii i pediatrii = Russian Bulletin of Perinatology and Pediatrics, 2016, vol. 61, no. 3, pp. 12–21. doi: 10.21508/1027-4065-2016-61-3-12-21 (In. Russ.)]</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6.Раввин Н.В., Шестаков С.В. Геном прокариот // Вавиловский журнал генетики и селекции. 2013. Т. 17, № 4/2. С. 972– 984. [Ravvin N.V., Shestakov S.V. The Genome of prokaryotes. Vavilovskii zhurnal genetiki i selektsii = Vavilov Journal of Genetics and Breeding, 2013, vol. 17, no. 4/2, pp. 972–984. (In. Russ.)]</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7.Романцев М.Г., Ершов Ф.И. Часто болеющие дети: современная фармакотерапия. М.: ГЭОТАР-Медиа, 2006. 192 с. [Romantsev M.G., Ershov F.I. Chasto boleyushchie deti: sovremennaya farmakoterapiya [Frequently ill children: modern pharmacotherapy]. Moscow: GEOTAR-Media, 2006. 192 p.]</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8.Романцов М.Г., Мельникова И.Ю. Часто болеющие дети: вопросы фармакотерапии (научный обзор) // Terra medica. 2014. № 1. С. 55–69. [Romantsov M.G., Melnikova I.Yu. Sickly children: issues of pharmacotherapy (scientific review). Terra Medica, 2014, no. 1, pp. 55–69. (In. Russ.)]</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9.Патент 2576839 Российская Федерация. Способ диагностики дисбиотических нарушений в биоптатах слизистой носа и глотки у детей раннего и дошкольного возраста с постоянно рецидивирующими острыми респираторными инфекциями / Тюменев А.В., Шабалдина Е.В., Шабалдин А.В., Рязанцев С.В., Симбирцев А.С. Заявители и патенто-обладатели: Тюменев А.В., Шабалдина Е.В., Шабалдин А.В., Рязанцев С.В., Симбирцев А.С.; завл. 16.10.2013; опубл. 10.03.2016 [Patent 2576839 Russian Federation. A method for diagnosing dysbiotic disorders in biopsies of nasal mucosa and pharynx in children of early and preschool age with recurring acute respiratory infections / Tyumenev A.V., Shabaldina E.V., Shabaldin A.V., Ryazantsev S.V., Simbirtsev A.S. Applicants and patent holders: Tyumenev A.V., Shabaldina E.V., Shabaldin A.V., Ryazantsev S.V., Simbirtsev A.S.; stat. 10.16.2013; publ. 03.10.2016]</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10.Патент 2569054 Российская Федерация. Способ определение провоспалительных и проаллергических интерлей-кинов в назальном секрете у детей раннего и дошкольного возраста для диагностики этиологии рецидивирующих острых ринофарингитов и аденоидитов / Тюменев А.В., Шабалдина Е.В., Шабалдин А.В., Симбирцев А.С., Рязан-цев С.В. Заявитель и патентообладатель ГБОУ ВПО Кемеровская государственная медицинская академия МЗ РФ; заявл. 24.09.2013; опубл. 20.11.2014 [Patent 2569054 Russian Federation. Method for the determination of proinflammatory and proallergic interleukins in nasal secretion in children of early and preschool age for diagnosis of the etiology of recurrent acute rhinopharyngitis and adenoiditis / Tyumenev A.V., Shabaldina E.V., Shabaldin A.V., Simbirtsev A.S., Ryazantsev S.V. Applicant and patent holder: Kemerovo State Medical Academy, Ministry of Health of the Russian Federation; stat. 24.09.2013; publ. 20.11.2014]</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11.Шабалдина Е.В., Кутенкова Н.Е, Шабалдин А.В., Лисаченко Г.В. Особенности иммунного и цитокинового статусов у детей с гипертрофией лимфоидного глоточного кольца и сопутствующей аллергией к инфекционным антигенам // Российская оториноларингология. 2012. № 2. С. 118–123. [Shabalina E.V., Kutenkova N.E., Shabaldin A.V., Tikhonuk V.P., Lisachenko G.V. Characteristics of immune and cytokine status in children with hypertrophy of lymphoid pharyngeal ring and concomitant allergies to infectious antigens. Rossiiskaya otorinolaringologiya = Russian Otorhinolaryngology, 2012, no. 2, pp. 118– 123. (In. Russ.)]</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12.Шабалдина Е.В., Кутенкова Н.Е., Шабалдин А.В., Тихонюк В.П., Лисаченко Г.В. Роль сенсибилизации к инфек-ционным антигенам в патогенезе рецидивирования острых респираторных инфекций у детей // Педиатрия. 2013. № 1. С. 24–33. [Shabalina E.V., Kutenkova N.E., Shabaldin A.V., Tikhonuk V.P., Lisachenko G.V. The role of sensitization to infectious antigens in the pathogenesis of recurrence of acute respiratory infections in children. Pediatriya = Pediatrics, 2013, no. 1, pp. 24–33. (In. Russ.)]</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13.Шестаков С.В. Как происходит и чем лимитируется горизонтальный перенос генов у бактерий // Экологическая генетика. 2007. Т. 2, № 5. С. 12–24. [Shestakov S.V. How is and then is limited by horizontal gene transfer in bacteria. Ekologicheskaya genetika = Ecological Genetics, 2007, vol. 2, no. 5, pp. 12–24. (In. Russ.)]</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14.Шестаков С.В. Метагеномика микробиома человека // Успехи современной биологии. 2010. Т. 130, № 6. С. 531–543. [Shestakov S.V. Metagenomics of the human microbiome. Uspekhi sovremennoi biologii = Advances in Current Biology, 2010, vol. 130, no. 6, pp. 531–543. (In. Russ.)]</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15.Щеплягина Л.А. Секреторный иммунитет кишечника у детей раннего возраста // Педиатрия. 2011. № 3. С. 48–50. [Schepljagina L.A. Secretory immune system of the intestine at children of early age. Pediatriya = Pediatrics, 2011, no. 3, pp. 48–50. (In. Russ.)]</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>16.Bassis C.M., Erb-Downward J.R., Dickson R.P., Freeman C.M., Schmidt T.M., Yong V.B., Beck J.M., Curtis J.L., Huffnagle G.B., Ravel J. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. MBio, 2015, vol. 6, no. 2: e00037-15. doi: 10.1128/mBio.00037-15</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>17.Benninger M., Brook I., Bernstein J.M., Casey J.R., Roos K., Marple B., Farrar J.R. Bacterial interference in upper respiratory tract infections: a systematic review. Am. J. Rhinolm. Allergy, 2011, vol. 25, no. 2, pp. 82–88. doi: 10.2500/ajra.2011.25.3594</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>18.Biesbroek G., Tsivtsivadze E., Sanders E.A., Montijn R., Veenhoven R.H., Keijser B.J. Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children. Am. J. Respir. Crit. Care Med., 2014, vol. 190, no. 11, pp. 1283–1292. doi: 10.1164/rccm.201407-1240OC</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>19.Bochkov Y.A., Grindle K., Vang F., Evans M.D., Gern J.E. Improved molecular typing assay for rhinovirus species A, B, and C. J. Clin. Microbiol., 2014, vol. 52, no. 7, pp. 2461–2471. doi: 10.1128/JCM.00075-14</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>20.Bogaert D., Keijser B., Huse S., Rossen J., Veenhoven R., Van Gils E., Bruin J., Montijn R., Bonten M., Sanders E. Variability and diversity of nasopharyngeal microbiota in children: a metagenomic analysis. PLoS One, 2011, vol. 6, no. 2, pp. 17035–17043. doi: 10.1371/journal.pone.0017035</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>21.Bogaert D., van Belkum A., Sluijter M., Luijendijk A., de Groot R., Rumke H.C. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet, 2004, vol. 363, iss. 9424, pp. 1871–1872. doi: 10.1016/S0140-6736(04)16357-5</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>22.Costello E.K., Lauber C.L., Hamady M., Fierer N., Gordon J.I., Knight R. Bacterial community variation in human body habitats across space and time. Science, 2009, vol. 326, iss. 5960, pp. 1694–1697. doi: 10.1126/science.1177486</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>23.Dickson R.P., Erb-Downward J.R., Huffnagle G.B. The role of the bacterial microbiome in lung disease. Expert Rev. Respir. Med., 2013, vol. 7, iss. 3, pp. 245–257. doi: 10.1586/ers.13.24</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>24.Dickson R.P., Erb-Downward J.R., Martinez F.J., Huffnagle G.B. The microbiome and the respiratory tract. Annu. Rev. Physiol., 2016, vol. 78, pp. 481–504. doi: 10.1146/annurev-physiol-021115-105238</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>25.Dickson R.P., Martinez F.J., Huffnagle G.B. The role of the microbiome in exacerbations of chronic lung diseases. Lancet, 2014, vol. 384, iss. 9944, pp. 691–702. doi: 10.1016/S0140-6736(14)61136-3</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>26.Edwards R.A., Rohwer F. Viral metagenomics. Nat. Rev. Microbiol., 2005, vol. 3, pp. 504–510. doi: 10.1038/nrmicro1163</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>27.Gao Z., Kang Y., Jun Y., Ren L. Human pharyngeal microbiome may play a protective role in respiratory tract infections. Genom. Proteom. Bioinformat., 2014, vol. 12, iss. 3, pp. 144–150. doi: 10.1016/j.gpb.2014.06.001</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>28.Hilty M., Burke C., Pedro H., Cardenas P., Bush A., Bossley C., Davies J., Ervine A., Poulter L., Pachter L., Moffatt M.F., Cookson W.O. Disordered microbial communities in asthmatic airways. PLoS One, 2010, vol. 5, iss. 1, e:8578. doi: 10.1371/journal.pone.0008578</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>29.Jensen A., Fago-Olsen H., Sorensen C.H., Kilian M. Molecular mapping to species level of the tonsillar crypt microbiota associated with health and recurrent tonsillitis. PLoS One, 2013, vol. 8, iss. 2: e56418. doi: 10.1371/journal.pone.0056418</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>30.Kononen E. Development of oral bacterial flora in young children. Ann. Med, 2000, vol. 32, iss. 2, pp. 107–112. doi: 10.3109/ 07853890009011759</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>31.Kumar H., Lund R., Laiho A., Lundelin K., Ley R.E., Isolauri E., Salminen S. Gut microbiota as an epigenetic regulator: pilot study based on whole-genome methylation analysis. MBio, 2014, vol. 5, no. 6: e02113-14. doi: 10.1128/mBio.02113-14</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>32.Lebon A., Labout J.A., Verbrugh H.A., Jaddoe V.W., Hofman A., van Wamel W., Moll H.A., van Belkam A. Dynamics and determinants of Staphylococcus aureus carriage in infancy: the Generation R Study. J. Clin. Microbiol., 2008, vol. 46, no. 10, pp. 3517–3521. doi: 10.1128/JCM.00641-08</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>33.Lee W.-M., Grindle K., Pappas T., Marshall D.J., Moser M.J., Beaty E.L., Shult P.A., Prudent J.R., Gern J.E. High-throughput, sensitive, and accurate multiplex PCR-microsphere flow cytometry system for large-scale comprehensive detection of respiratory viruses. J. Clin. Microbiol., 2007, vol. 45, no. 8, pp. 2626–2634. doi: 10.1128/JCM.02501-06</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>34.Liu C.M., Cosetti M.K., Aziz M., Buchhagen J.L., Contente-Cuomo T.L., Price L.B., Keim P.S., Lalwani A.K. The otologic microbiome: a study of the bacterial microbiota in a pediatric patient with chronic serous otitis media using 16SrRNA gene-based pyrosequencing. Arch. Otolaryngol. Head Neck Surg., 2011, vol. 137, no. 7, pp. 664–668. doi: 10.1001/archoto.2011.116</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>35.Lysholm F., Wetterbom A., Lindau C., Darban H., Bjerkner A., Fahlander K., Lindberg A.M., Persson B., Allander T., Anders-son B. Characterization of the viral microbiome in patients with severe lower respiratory tract infections, using metagenomic sequencing. PLoS One, 2012, vol. 7, no. 2: e30875. doi: 10.1371/journal.pone.0030875</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>36.Malygina O.G., Bazhukova T.A. Influence of antibiotics on formation of microecology in premature children with low and extremely low body weight at birth. J. Microbiol. Epidemiol. Immunobiol., 2014, no. 1, pp. 61–65. PMID: 24738296</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>37.Moore H.C., Jacoby P., Taylor A., Harnett G., Bowman J., Riley T.V., Smith D.W., Lehmann D. The interaction between respiratory viruses and pathogenic bacteria in the upper respiratory tract of asymptomatic aboriginal and non-aboriginal children. Pediatr. Infect. Dis. J., 2010, vol. 29, iss. 6, pp. 540–545. doi: 10.1097/inf.0b013e3181d067cb</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>38.Peterson S.W., Knox N.C., Golding G.R., Tyler S.D., Tyler A.D., Mabon P., Embree J.E., Fleming F., Fanella S., van Domselaar G., Mulvey M.R., Graham M.R. A study of the infant nasal microbiome development over the first year of life and in relation to their primary adult caregivers using cpn60 universal target (UT) as a phylogenetic marker. PLoS One, 2016, vol. 11, no. 3: e0152493. doi: 10.1371/journal.pone.0152493</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>39.Quintero B., Araque M., van der Gaast-de Jongh C., Escalona F., Correa M., Morillo-Puente S., Vielma S., Hermans P.W.M. Epidemiology of Streptococcus pneumoniae and Staphylococcus aureus colonization in healthy Venezuelan children. Eur. J. Clin. Microbiol. Infect. Dis., 2011, vol. 30, iss. 1, pp. 7–19. doi: 10.1007/s10096-010-1044-6</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>40.Rajeschwary A., Rai S., Somayaji G., Pai V. Bacteriology of symptomatic adenoids in children. North Am. J. Med. Sci., 2013, vol. 5, no. 2, pp. 113–118. doi: 10.4103/1947-2714.107529</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>41.Ren T., Ulrike D.G., Nguyen T.N., Kaitlynn E.A., Early S.V., Sale M., Winther B., Wu M. 16S rRNA survey revealed complex bacterial communities and evidence of bacterial interference on human adenoids. Environ. Microbiol., 2012, vol. 15, no. 2, pp. 2–13. doi: 10.1111/1462-2920.12000</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>42.Sakwinska O., Schmid V.B., Berger B., Bruttin A., Keitel K., Lepage M., Moine D., Bru C.N., Brüssow H., Gervaix A. Nasopharyngeal microbiota in healthy children and pneumonia patients. J. Clin. Microbiol., 2014, vol. 52, no. 5, pp. 1590–1594. doi:10.1128/JCM.03280-13</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>43.Santee C.A., Nagalingam N.A., Faruqi A.A., DeMuri G.P., Gern J.E., Wald E.R., Lynch S.V. Nasopharyngeal microbiota composition of children is related to the frequency of upper respiratory infection and acute sinusitis. Microbiome, 2016, vol. 4: 34. doi: 10.1186/s40168-016-0179-9</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>44.Scholz C.F., Poulsen K., Kilian M. Novel molecular method for identification of Streptococcus pneumoniae applicable to clinical microbiology and 16S rRNA sequence-based microbiome studies. J. Clin. Microbiol., 2012, vol. 50, no. 6, pp. 1968–1973. doi: 10.1128/JCM.00365-12</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>45.Shilts M.H., Rosas-Salazar C., Tovchigrechko A., Larkin E.K., Torralba M., Akopov A., Halpin R., Peebles R.S., Moore M.L., Anderson L.J., Nelson K.E., Hartert T.V., Das S.R. Minimally invasive sampling method identifies differences in taxonomic richness of nasal microbiomes in young infants associated with mode of delivery. Microb. Ecol., 2016, vol. 71, iss. 1, pp. 233–242. doi: 10.1007/s00248-015-0663-y</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>46.Stearns J.C., Davidson C.J., McKeon S., Whelan F.J., Fontes M.E., Schryvers A.B., Bowdish D.M., Kellner J.D., Surette M.G. Culture and molecular-based profiles show shifts in bacterial communities of the upper respiratory tract that occur with age. ISME J., 2015, no. 9, pp. 1246–1259. doi: 10.1038/ismej.2014.250</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>47.Structure, function and diversity of the healthy human microbiome. The Human Microbiome Project Consortium. Nature, 2012, vol. 486, no. 7402, pp. 201–214. doi: 10.1038/nature11234</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>48.Teo S.M., Mok D., Pham K., Kusel M., Serralha M., Troy N., Holt B.J., Hales B.J., Walker M.V., Hollams E., Bochkov Y.A., Grindle K., Johnston S.L., Gern J.E., Sly P.D., Holt P.G., Holt K.E., Inouye M. The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host &amp; Microbe, 2015, vol. 17, no. 5, pp. 704–715. doi: 10.1016/j.chom.2015.03.008</mixed-citation></ref></ref-list></back></article>
